Citigroup Inc Imago Bio Sciences, Inc. Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$15.03 - $35.96 $9,078 - $21,719	-604 Reduced 52.39%	549 $19,000
Q3 2022 Nov 10, 2022	SELL	$14.15 - $19.5 $20,758 - $28,606	-1,467 Reduced 55.99%	1,153 $17,000
Q2 2022 Aug 10, 2022	BUY	$11.81 - $20.92 $8,833 - $15,648	748 Added 39.96%	2,620 $35,000
Q1 2022 May 12, 2022	SELL	$16.97 - $25.0 $30,444 - $44,850	-1,794 Reduced 48.94%	1,872 $36,000
Q4 2021 Feb 10, 2022	BUY	$16.22 - $29.69 $35,018 - $64,100	2,159 Added 143.26%	3,666 $87,000
Q3 2021 Nov 10, 2021	BUY	$16.0 - $28.84 $24,112 - $43,461	1,507 New	1,507 $30,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.